These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7906190)

  • 1. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine.
    Eisen A; Stewart H; Schulzer M; Cameron D
    Can J Neurol Sci; 1993 Nov; 20(4):297-301. PubMed ID: 7906190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B; Pappagallo M; Knotkova H; Guleyupoglu N; Wallenstein S; Portenoy RK
    Clin Ther; 2007 Sep; 29(9):2022-30. PubMed ID: 18035201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
    Ryberg H; Askmark H; Persson LI
    Acta Neurol Scand; 2003 Jul; 108(1):1-8. PubMed ID: 12807386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.
    Mills KR
    Brain; 2003 Nov; 126(Pt 11):2558-66. PubMed ID: 12937082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cortical silent period and amyotrophic lateral sclerosis.
    Prout AJ; Eisen AA
    Muscle Nerve; 1994 Feb; 17(2):217-23. PubMed ID: 8114792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis.
    Stefan K; Kunesch E; Benecke R; Classen J
    Ann Neurol; 2001 Apr; 49(4):536-9. PubMed ID: 11310635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor cortex stimulation for ALS: a double blind placebo-controlled study.
    Di Lazzaro V; Pilato F; Profice P; Ranieri F; Musumeci G; Florio L; Beghi E; Frisullo G; Capone F; Sabatelli M; Tonali PA; Dileone M
    Neurosci Lett; 2009 Oct; 464(1):18-21. PubMed ID: 19682544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
    Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
    J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological assessment in lamotrigine treated epileptic patients.
    Banks GK; Beran RG
    Clin Exp Neurol; 1991; 28():230-7. PubMed ID: 1821833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer factor is ineffective in amyotrophic lateral sclerosis.
    Olarte MR; Gersten JC; Zabriskie J; Rowland LP
    Ann Neurol; 1979 Apr; 5(4):385-8. PubMed ID: 443772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.